• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Layoffs 10/01/24

anonymous

Guest
Well, it happened. I heard 2% headcount reduction worldwide, including myself (over 10 years at PDCO). Heavy cuts in service and support. Odd move for a company which cannot compete on price, whose only competitive advantage in the marketplace is “superior service and support”

Also an odd move for a company that is well known to not pay their employees a competitive wage, and only attracts and retains talent based on their culture, training, and work life balance.

But again, what do I know? Cheers to all those affected.